2022
DOI: 10.7759/cureus.23881
|View full text |Cite
|
Sign up to set email alerts
|

New-Onset Hypothyroidism Manifesting As Myxedema Coma: Fighting an Old Enemy

Abstract: Myxedema coma (MC) is a rare manifestation of severe hypothyroidism. This is a true endocrine emergency that may remain unrecognized. We present a case of a 49-year-old man who presented to the emergency department with generalized weakness and confusion. He was found to have low temperature, bradycardia, hypoxia, hypotension, glucose of 59 mg/dL, normal electrolytes, thyroid-stimulating hormone of 154 IU/mL, and free T4 of 0.1 ng/dL. His anti-peroxidase antibody level was 99 IU/mL. Echocardiography revealed a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 22 publications
0
2
0
Order By: Relevance
“…Blood flow may be compromised by bowel distention, causing ischemia ( Riaz et al, 2020 ). Pseudo-obstruction is rarely observed and are usually linked to myxedema coma or severe hypothyroidism ( Santos Argueta et al, 2022 ). Individuals may be responsive to a treatment regime of intravenous triiodothyronine (T3), that is commonly used for treating myxedema coma ( Santos Argueta et al, 2022 ).…”
Section: Hypothyroidism and Gi Motilitymentioning
confidence: 99%
See 1 more Smart Citation
“…Blood flow may be compromised by bowel distention, causing ischemia ( Riaz et al, 2020 ). Pseudo-obstruction is rarely observed and are usually linked to myxedema coma or severe hypothyroidism ( Santos Argueta et al, 2022 ). Individuals may be responsive to a treatment regime of intravenous triiodothyronine (T3), that is commonly used for treating myxedema coma ( Santos Argueta et al, 2022 ).…”
Section: Hypothyroidism and Gi Motilitymentioning
confidence: 99%
“…Pseudo-obstruction is rarely observed and are usually linked to myxedema coma or severe hypothyroidism ( Santos Argueta et al, 2022 ). Individuals may be responsive to a treatment regime of intravenous triiodothyronine (T3), that is commonly used for treating myxedema coma ( Santos Argueta et al, 2022 ). Unrecognized hypothyroidism may result in increased colonic surgery morbidity or may lead to fatal outcome causing unnecessary procedures ( Bergeron et al, 1997 ).…”
Section: Hypothyroidism and Gi Motilitymentioning
confidence: 99%